Nevus Support Australia Inc

20/01/2026

Sign up to Melanoma March or sponsor someone participating and help raise funds for research that not only impacts outcomes for Melanoma patients but builds understanding for a range of conditions including CMN and NCM.

Melanoma March events are held around Australia during March to raise vital funds for melanoma research and increase awareness of melanoma. The events also provide an opportunity for patients, families and communities to come together to support each other and remember those lost to the disease.

06/11/2025

10/10/2025

01/09/2025

The International Neoadjuvant Melanoma Consortium (INMC), of which MIA’s Professor Georgina Long is a founder with three colleagues from MD Anderson Cancer Center USA, has been awarded the 2025 Society for Immunotherapy of Cancer (SITC) Collaboration Award for its work in pioneering neoadjuvant immunotherapy for melanoma.

The award recognizes key collaborators in the field that have helped move cancer immunotherapy forward by collaborating with various stakeholders, including across geographic regions.

The consortium commenced in 2016, and since that time has grown to include > 500 clinician and researcher members from around the world, with executive leadership from Melanoma Institute Australia Faculty, alongside colleagues from MD Anderson USA, The Netherlands, and Italy.

‘As one of the founders and leaders of the International Neoadjuvant Melanoma Consortium, I am so proud of what we have achieved, including MIA’s role within the consortium to progress practice-changing neoadjuvant drug therapy clinical trials. Neoadjuvant, or pre-surgery drug therapy has turned the melanoma treatment paradigm on its head and has untold potential to also impact other cancers and save countless lives,’ - Prof Georgina Long

Results from the NADINA neoadjuvant clinical trial, jointly led by MIA’s Prof Long and The Netherlands Cancer Institute's Prof Blank, led to Australia recently becoming the first country in the world to subsidise neoadjuvant immunotherapy for Stage III melanoma patients.

Read more > https://melanoma.org.au/news/global-award-for-neoadjuvant-immunotherapy/

09/08/2025

It's a full moon tonight, so it's time for a self-skin check! Use the full moon as your monthly reminder to take action and check your skin.

Here's how: https://melanomapatients.org.au/prevention/early-detection/

31/07/2025

Congratulations to MIA Medical Director Professor Georgina Long AO, named as a Fellow of the American Society of Clinical Oncology (FASCO).

The American Society of Clinical Oncology (ASCO) is the world's leading professional organisation for physicians and oncology professionals caring for people with cancer. Its mission is to conquer cancer through research, education, and promotion of the highest quality patient care.

This prestigious fellowship honours individuals who have made significant contributions to ASCO, the practice of clinical oncology, people with cancer, and activities that impact public awareness about cancer, its causes, cures, and treatment.

23/06/2025

The third and final webinar in our Melanoma Community Webinar Series with is tomorrow evening (Tuesday 24 June) 7-8pm AEST via Zoom.

This webinar will take a deep dive into sunscreen, and taking you through this topic will be MIA Dermatologist, Dr Annika Smith & Head of Medical Relations at La Roche-Posay, Rachel McAdam.

Our Melanoma Patients Australia Community member Allie Joynt will also share her personal experience.

Register now for this free event via the link below 👇
https://bit.ly/4kLjDZM

If you missed the first two webinars in the series you can listen to them on our website:
Webinar 1: Genetic testing for Melanoma 👇https://melanomapatients.org.au/mpa-mia-community-webinar-series-2025-genetic-testing-for-melanoma/

Webinar 2: Understanding melanoma drug therapy and the new era of neoadjuvant👉 https://melanomapatients.org.au/mpa-mia-community-webinar-series-2025-understanding-melanoma-drug-therapy-and-the-new-era-of-neoadjuvant/

10/02/2025

A valued and highly respected friend. Rest in peace - your work here is done 🖤

The Nevus Outreach family is deeply saddened by the loss of our co-founder, Kathy Stewart. Kathy's journey began in 1997 when she, along with five other parents, found solace and connection online while navigating the challenges of raising children with CMN and related conditions. From this connection, Nevus Outreach was born! Just one year later, our first conference in Orlando exceeded all expectations. Kathy's dedication to connecting families with leading researchers, including Dr. Harper Price, has been instrumental to our progress.

Her passion for the CMN Fellowship Fund touched her heart, and her family has requested that memorial gifts be directed to this vital initiative: nevus.org/kathy

27/09/2023

Dots and spots unite us here.
If you would like to, how about we help these reception children feel connected through dots too 😃⚫️⚫️⚫️

25/02/2023

The SunSmart app has been updated and will become redundant soon. Please follow this link to update to the new app, which now gives you a global UV level reading, so you can take care of your skin no matter where you are :) ☀️

Sunsmart App. UV cannot be seen or felt, use the SunSmart app to check daily sun protection times for your location each day.

27/01/2023

International Alliance of Dermatology Patient Organizations - IADPO
The Australasian College of Dermatologists
Melanoma Institute Australia